Press Releases
Archives: Search / 2016 / 2015 / 2014 / 2013 / 2012
2011 Archives
12/27/2011 Neuralstem's NSI-189 Trial in Major Depressive Disorder Receives FDA Approval to Advance to Phase Ib First Neuroregenerative Compound Tested In Depression
|
09/12/2011 Live Webcast to Air on Tuesday, September 13, at 10:50 a.m. EDT
|
06/14/2011 APPROVED BY SAFETY MONITORING BOARD TO MOVE TO CERVICAL TRANSPLANTATIONS
|
04/06/2011 PRINCIPAL INVESTIGATOR, DR. EVA FELDMAN, TO PRESENT SAFETY DATA
|
1-25 26-29 |